Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Multiplatform Investigation of Plasma and Tissue Lipid Signatures of Breast Cancer Using Mass Spectrometry Tools

Full text
Author(s):
Show less -
Rosini Silva, Alex Ap. [1] ; Cardoso, Marcella R. [2] ; Rezende, Luciana Montes [2] ; Lin, John Q. [3] ; Guimaraes, Fernando [2] ; Paiva Silva, Geisilene R. [4] ; Murgu, Michael [5] ; Priolli, Denise Goncalves [1] ; Eberlin, Marcos N. [6] ; Tata, Alessandra [7] ; Eberlin, Livia S. [3] ; Derchain, Sophie F. M. [2] ; Porcari, Andreia M. [1]
Total Authors: 13
Affiliation:
[1] Sao Francisco Univ, Postgrad Program Hlth Sci, BR-12916900 Braganca Paulista, SP - Brazil
[2] State Univ Campinas UNICAMP, Fac Med Sci, Dept Gynecol & Breast Oncol, Womens Hosp CAISM, BR-13083881 Campinas, SP - Brazil
[3] Univ Texas Austin, Dept Chem, Austin, TX 78712 - USA
[4] State Univ Campinas UNICAMP, Fac Med Sci, Womens Hosp CAISM, Lab Mol & Investigat Pathol, BR-13083881 Campinas, SP - Brazil
[5] Waters Corp, BR-13083970 Sao Paulo, SP - Brazil
[6] Univ Prebiteriana Mackenzie, Sch Engn, BR-01302907 Sao Paulo, SP - Brazil
[7] Ist Zooprofilatt Sperimentale Venezie, Lab Chim Sperimentale, Viale Fiume 78, I-36100 Vicenza - Italy
Total Affiliations: 7
Document type: Journal article
Source: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; v. 21, n. 10 MAY 2020.
Web of Science Citations: 0
Abstract

Plasma and tissue from breast cancer patients are valuable for diagnostic/prognostic purposes and are accessible by multiple mass spectrometry (MS) tools. Liquid chromatography-mass spectrometry (LC-MS) and ambient mass spectrometry imaging (MSI) were shown to be robust and reproducible technologies for breast cancer diagnosis. Here, we investigated whether there is a correspondence between lipid cancer features observed by desorption electrospray ionization (DESI)-MSI in tissue and those detected by LC-MS in plasma samples. The study included 28 tissues and 20 plasma samples from 24 women with ductal breast carcinomas of both special and no special type (NST) along with 22 plasma samples from healthy women. The comparison of plasma and tissue lipid signatures revealed that each one of the studied matrices (i.e., blood or tumor) has its own specific molecular signature and the full interposition of their discriminant ions is not possible. This comparison also revealed that the molecular indicators of tissue injury, characteristic of the breast cancer tissue profile obtained by DESI-MSI, do not persist as cancer discriminators in peripheral blood even though some of them could be found in plasma samples. (AU)

FAPESP's process: 16/07822-4 - Analysis Of Molecular Biomarkers Associated To Chemoresistance Derived From Breast Cancer Stem Cells
Grantee:Sophie Françoise Mauricette Derchain
Support Opportunities: Regular Research Grants
FAPESP's process: 19/04314-6 - Imaging and mass spectrometry-based metabolomics applied to the study of drug resistance in neoadjuvant therapy for breast cancer: the search for a predictive test
Grantee:Andréia de Melo Porcari
Support Opportunities: Regular Research Grants